Alnylam Pharmaceuticals
ALNY
#662
Rank
โ‚น2.634 T
Marketcap
โ‚น20,347
Share price
-4.68%
Change (1 day)
64.91%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

EPS for Alnylam Pharmaceuticals (ALNY)

EPS in 2023 (TTM): -โ‚น337.20

According to Alnylam Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น358.81. In 2022 the company made an earnings per share (EPS) of -โ‚น811.03 a decrease over its 2021 EPS that were of -โ‚น628.57.

EPS history for Alnylam Pharmaceuticals from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น337.20-58.42%
2022-โ‚น811.0329.03%
2021-โ‚น628.57-3.36%
2020-โ‚น650.39-8.48%
2019-โ‚น710.637.67%
2018-โ‚น660.0039.74%
2017-โ‚น472.3012.94%
2016-โ‚น418.1738.84%
2015-โ‚น301.19-32.88%
2014-โ‚น448.73259.44%
2013-โ‚น124.84-31.25%
2012-โ‚น181.5952.94%
2011-โ‚น118.7330.77%
2010-โ‚น90.79-8.77%
2009-โ‚น99.5278.13%
2008-โ‚น55.87-70.78%
2007-โ‚น191.1999.09%
2006-โ‚น96.03-43.88%
2005-โ‚น171.11-82.33%
2004-โ‚น968.46-59.23%
2003-โ‚น2,375

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น148.41-58.64%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3,262-1,009.00%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น683.57 90.51%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น23.57-93.43%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น147.54-58.88%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น326.51-191.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น277.64-177.38%๐Ÿ‡ซ๐Ÿ‡ท France
-โ‚น174.60-51.34%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel